Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet?

References

• Plotkin SL, Plotkin SA. A short history of vaccination. In: Vaccines. Plotkin SA, Orenstein WA (Eds). Saunders, PA, USA 1–15 (2004).
   Google Scholar
• Germanier R, Fuer E. Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. J. Infect. Dis.131(5), 553–558 (1975).
   PubMed Web of Science ®Google Scholar
• Kaper JB, Levine MM. Cloned cholera enterotoxin genes in study and prevention of cholera. Lancet2(8256), 1162–1163 (1981).
   PubMedGoogle Scholar
• Kaper JB, Lockman H, Baldini MM, Levine MM. Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates. Nature308(5960), 655–658 (1984).
   PubMed Web of Science ®Google Scholar
• Levine MM, Kaper JB, Herrington D et al. Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. Lancet2(8609), 467–470 (1988).
   PubMed Web of Science ®Google Scholar
• Tacket CO, Losonsky G, Nataro JP et al. Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR. J. Infect. Dis.166(4), 837–841 (1992).
   PubMed Web of Science ®Google Scholar
• Chatfield SN, Fairweather N, Charles I et al. Construction of a genetically defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine. Vaccine10(1), 53–60 (1992).
   PubMed Web of Science ®Google Scholar
• Hone DM, Harris AM, Chatfield S, Dougan G, Levine MM. Construction of genetically defined double aro mutants of Salmonella typhi.Vaccine9(11), 810–816 (1991).
   PubMed Web of Science ®Google Scholar
• Roland KL, Tinge SA, Killeen KP, Kochi SK. Recent advances in the development of live, attenuated bacterial vectors. Curr. Opin. Mol. Ther.7(1), 62–72 (2005).
   PubMedGoogle Scholar
• Dietrich G, Spreng S, Favre D, Viret JF, Guzman CA. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines. Curr. Opin. Mol. Ther.5(1), 10–19 (2003).
   PubMed Web of Science ®Google Scholar
• Shata MT, Stevceva L, Agwale S, Lewis GK, Hone DM. Recent advances with recombinant bacterial vaccine vectors. Mol. Med. Today6(2), 66–71 (2000).
   PubMedGoogle Scholar
• Brown A, Hormaeche CE, Demarco de Hormaeche R et al. An attenuated aroA Salmonella typhimurium vaccine elicits humoral and cellular immunity to cloned β-galactosidase in mice. J. Infect. Dis.155(1), 86–92 (1987).
   PubMed Web of Science ®Google Scholar
• Gonzalez C, Hone D, Noriega FR et al.Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans. J. Infect. Dis.169(4), 927–931 (1994).
   PubMed Web of Science ®Google Scholar
• Aggarwal A, Kumar S, Jaffe R, Hone D, Gross M, Sadoff J. Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells. J. Exp. Med.172(4), 1083–1090 (1990).
   PubMed Web of Science ®Google Scholar
• Sadoff JC, Ballou WR, Baron LS et al. Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria. Science240(4850), 336–338 (1988).
   PubMed Web of Science ®Google Scholar
• Russmann H, Shams H, Poblete F, Fu Y, Galan JE, Donis RO. Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science281(5376), 565–568 (1998).
   PubMed Web of Science ®Google Scholar
• Sizemore DR, Branstrom AA, Sadoff JC. Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization. Science270(5234), 299–302 (1995).
   PubMed Web of Science ®Google Scholar
• Galen JE, Pasetti MF, Sztein MB, Barry EM, Levine MM. Attenuated Salmonella and Shigella as live vectors carrying either prokaryotic or eukaryotic expression systems. In: New Generation Vaccines. Levine MM, Kaper JB, Rappuoli R, Liu MA, Good MA (Eds). Marcel Dekker, NY, USA 353–365 (2004).
   Google Scholar
• Levine MM, Kaper JB, Rappuoli R, Liu MA, Good MA. New Generation Vaccines. Marcel Dekker, NY, USA (2004).
   Google Scholar
• Plotkin SA, Orenstein WA, Offit PA. Vaccines Saunders, PA, USA (2004).
   Google Scholar
• Clements JD, El-Morshidy S. Construction of a potential live oral bivalent vaccine for typhoid fever and cholera-Escherichia coli-related diarrheas. Infect. Immun.46(2), 564–569 (1984).
   PubMed Web of Science ®Google Scholar
• Newton SM, Jacob CO, Stocker BA. Immune response to cholera toxin epitope inserted in Salmonella flagellin. Science244(4900), 70–72 (1989).
   PubMed Web of Science ®Google Scholar
• Su GF, Brahmbhatt HN, de Lorenzo V, Wehland J, Timmis KN. Extracellular export of Shiga toxin B-subunit/ haemolysin A (C-terminus) fusion protein expressed in Salmonella typhimurium aroA-mutant and stimulation of B-subunit specific antibody responses in mice. Microb. Pathog.13(6), 465–476 (1992).
   PubMed Web of Science ®Google Scholar
• Gentschev I, Mollenkopf HJ, Sokolovic Z et al. Synthesis and secretion of bacterial antigens by attenuated Salmonella via the Escherichia coli hemolysin secretion system. Behring Inst. Mitt. (95), 57–66 (1994).
   Google Scholar
• Lo RY, Watt MA, Gyroffy S, Mellors A. Preparation of recombinant glycoprotease of Pasteurella haemolytica A1 utilizing the Escherichia coli α-hemolysin secretion system. FEMS Microbiol. Lett.116(2), 225–230 (1994).
   PubMed Web of Science ®Google Scholar
• Tacket CO, Forrest B, Morona R et al. Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid–cholera hybrid vaccine derived from Salmonella typhi Ty21a. Infect. Immun.58(6), 1620–1627 (1990).
   PubMed Web of Science ®Google Scholar
• Fairweather NF, Chatfield SN, Makoff AJ et al. Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier. Infect. Immun.58(5), 1323–1326 (1990).
   PubMed Web of Science ®Google Scholar
• Poirier TP, Kehoe MA, Beachey EH. Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein. J. Exp. Med.168(1), 25–32 (1988).
   PubMed Web of Science ®Google Scholar
• Tite JP, Gao XM, Hughes-Jenkins CM et al. Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. III. Delivery of recombinant nucleoprotein to the immune system using attenuated Salmonella typhimurium as a live carrier. Immunology70(4), 540–546 (1990).
   PubMed Web of Science ®Google Scholar
• Stone JL. On the mode of release of tetanus toxin from the bacterial cell. J. Bacteriol.67(1), 110–116 (1954).
   PubMed Web of Science ®Google Scholar
• Fouts TR, Lewis GK, Hone DM. Construction and characterization of a Salmonella typhi-based human immunodeficiency virus type 1 vector vaccine. Vaccine13(6), 561–569 (1995).
   PubMed Web of Science ®Google Scholar
• Fouts TR, Tuskan RG, Chada S, Hone DM, Lewis GK. Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120. Vaccine13(17), 1697–1705 (1995).
   PubMed Web of Science ®Google Scholar
• Wu S, Pascual DW, Lewis GK, Hone DM. Induction of mucosal and systemic responses against human immunodeficiency virus type 1 glycoprotein 120 in mice after oral immunization with a single dose of a Salmonella-HIV vector. AIDS Res. Hum. Retroviruses13(14), 1187–1194 (1997).
   PubMed Web of Science ®Google Scholar
• Berggren RE, Wunderlich A, Ziegler E et al. HIV gp120-specific cell-mediated immune responses in mice after oral immunization with recombinant Salmonella.J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.10(5), 489–495 (1995).
   PubMedGoogle Scholar
• DiPetrillo MD, Tibbetts T, Kleanthous H, Killeen KP, Hohmann EL. Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers. Vaccine18(5–6), 449–459 (1999).
   PubMed Web of Science ®Google Scholar
• Londono-Arcila P, Freeman D, Kleanthous H et al. Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming–parenteral boosting vaccination regimen. Infect. Immun.70(9), 5096–5106 (2002).
   PubMed Web of Science ®Google Scholar
• Metzger WG, Mansouri E, Kronawitter M et al. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar Typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine22(17–18), 2273–2277 (2004).
   PubMed Web of Science ®Google Scholar
• Tacket CO, Galen J, Sztein MB et al. Safety and immune responses to attenuated Salmonella enterica serovar Typhi oral live vector vaccines expressing tetanus toxin fragment C. Clin. Immunol.97(2), 146–153 (2000).
   PubMed Web of Science ®Google Scholar
• Angelakopoulos H, Hohmann EL. Pilot study of phoP/phoQ-deleted Salmonella enterica serovar Typhimurium expressing Helicobacter pylori urease in adult volunteers. Infect. Immun.68(4), 2135–2141 (2000).
   PubMed Web of Science ®Google Scholar
• Tacket CO, Kelly SM, Schodel F et al. Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system. Infect. Immun.65(8), 3381–3385 (1997).
   PubMed Web of Science ®Google Scholar
• Makrides SC. Strategies for achieving high-level expression of genes in Escherichia coli.Microbiol. Rev.60(3), 512–538 (1996).
   PubMedGoogle Scholar
• Hess J, Gentschev I, Miko D et al. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc. Natl Acad. Sci. USA93(4), 1458–1463 (1996).
   PubMed Web of Science ®Google Scholar
• Galen JE, Levine MM. Can a ‘flawless’ live vector vaccine strain be engineered? Trends Microbiol.9(8), 372–376 (2001).
   PubMed Web of Science ®Google Scholar
• Jagusztyn-Krynicka EK, Clark-Curtiss JE, Curtiss R 3rd. Escherichia coli heat-labile toxin subunit B fusions with Streptococcus sobrinus antigens expressed by Salmonella typhimurium oral vaccine strains: importance of the linker for antigenicity and biological activities of the hybrid proteins. Infect. Immun.61(3), 1004–1015 (1993).
   PubMed Web of Science ®Google Scholar
• Coulson NM, Fulop M, Titball RW. Bacillus anthracis protective antigen, expressed in Salmonella typhimurium SL 3261, affords protection against anthrax spore challenge. Vaccine12(15), 1395–1401 (1994).
   PubMed Web of Science ®Google Scholar
• Haddad D, Liljeqvist S, Kumar S et al. Surface display compared to periplasmic expression of a malarial antigen in Salmonella typhimurium and its implications for immunogenicity. FEMS Immunol. Med. Microbiol.12(3–4), 175–186 (1995).
   PubMed Web of Science ®Google Scholar
• Newton SM, Kotb M, Poirier TP, Stocker BA, Beachey EH. Expression and immunogenicity of a streptococcal M protein epitope inserted in Salmonella flagellin. Infect. Immun.59(6), 2158–2165 (1991).
   PubMed Web of Science ®Google Scholar
• Shams H, Poblete F, Russmann H, Galan JE, Donis RO. Induction of specific CD8+ memory T cells and long lasting protection following immunization with Salmonella typhimurium expressing a lymphocytic choriomeningitis MHC class I-restricted epitope. Vaccine20(3–4), 577–585 (2001).
   PubMed Web of Science ®Google Scholar
• Kotton CN, Lankowski AJ, Scott N et al. Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella Type III secretion system. Vaccine24(37–39), 6216–6224 (2006).
   PubMed Web of Science ®Google Scholar
• Evans DT, Chen LM, Gillis J et al. Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system. J. Virol.77(4), 2400–2409 (2003).
   PubMed Web of Science ®Google Scholar
• Vindurampulle CJ, Cuberos LF, Barry EM, Pasetti MF, Levine MM. Recombinant Salmonella enterica serovar Typhi in a prime–boost strategy. Vaccine22(27–28), 3744–3750 (2004).
   PubMed Web of Science ®Google Scholar
• Lasaro MO, Luiz WB, Sbrogio-Almeida ME, Ferreira LC. Prime–boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.Vaccine23(19), 2430–2438 (2005).
   PubMed Web of Science ®Google Scholar
• Courvalin P, Goussard S, Grillot-Courvalin C. Gene transfer from bacteria to mammalian cells. CR Acad. Sci. III318(12), 1207–1212 (1995).
   PubMed Web of Science ®Google Scholar
• Hone DM, Wu S, Powell RJ et al. Optimization of live oral Salmonella-HIV-1 vaccine vectors for the induction of HIV-specific mucosal and systemic immune responses. J. Biotechnol.44(1–3), 203–207 (1996).
   PubMed Web of Science ®Google Scholar
• Sizemore DR, Branstrom AA, Sadoff JC. Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization. Vaccine15(8), 804–807 (1997).
   PubMed Web of Science ®Google Scholar
• Darji A, Guzman CA, Gerstel B et al. Oral somatic transgene vaccination using attenuated S. typhimurium.Cell91(6), 765–775 (1997).
   PubMed Web of Science ®Google Scholar
• Paglia P, Medina E, Arioli I, Guzman CA, Colombo MP. Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. Blood92(9), 3172–3176 (1998).
   PubMed Web of Science ®Google Scholar
• Schoen C, Stritzker J, Goebel W, Pilgrim S. Bacteria as DNA vaccine carriers for genetic immunization. Int. J. Med. Microbiol.294(5), 319–335 (2004).
   PubMed Web of Science ®Google Scholar
• Daudel D, Weidinger G, Spreng S. Use of attenuated bacteria as delivery vectors for DNA vaccines. Expert Rev. Vaccines6(1), 97–110 (2007).
   PubMed Web of Science ®Google Scholar
• Devico AL, Fouts TR, Shata MT, Kamin-Lewis R, Lewis GK, Hone DM. Development of an oral prime–boost strategy to elicit broadly neutralizing antibodies against HIV-1. Vaccine20(15), 1968–1974 (2002).
   PubMed Web of Science ®Google Scholar
• Galen JE, Nair J, Wang JY et al. Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA. Infect. Immun.67(12), 6424–6433 (1999).
   PubMed Web of Science ®Google Scholar
• Bauer H, Darji A, Chakraborty T, Weiss S. Salmonella-mediated oral DNA vaccination using stabilized eukaryotic expression plasmids. Gene Ther.12(4), 364–372 (2005).
   PubMed Web of Science ®Google Scholar
• Gahan ME, Webster DE, Wesselingh SL, Strugnell RA. Impact of plasmid stability on oral DNA delivery by Salmonella enterica serovar Typhimurium. Vaccine25(8), 1476–1483 (2007).
   PubMed Web of Science ®Google Scholar
• Cicin-Sain L, Brune W, Bubic I, Jonjic S, Koszinowski UH. Vaccination of mice with bacteria carrying a cloned herpesvirus genome reconstituted in vivo.J. Virol.77(15), 8249–8255 (2003).
   PubMed Web of Science ®Google Scholar
• Pasetti MF, Barry EM, Losonsky G et al. Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats. J. Virol.77(9), 5209–5217 (2003).
   PubMed Web of Science ®Google Scholar
• Goussard S, Grillot-Courvalin C, Courvalin P. Eukaryotic promoters can direct protein synthesis in Gram-negative bacteria. J. Mol. Microbiol. Biotechnol.6(3–4), 211–218 (2003).
   PubMed Web of Science ®Google Scholar
• Woo PC, Tsoi HW, Leung HC, Yuen KY. Enhancement of humoral and protective immune response induced by live-attenuated Salmonella typhi by ampicillin. Apmis108(5), 343–348 (2000).
   PubMed Web of Science ®Google Scholar
• Garmory HS, Brown KA, Titball RW. Salmonella vaccines for use in humans: present and future perspectives. FEMS Microbiol. Rev.26(4), 339–353 (2002).
   PubMed Web of Science ®Google Scholar
• Castagliuolo I, Beggiao E, Brun P et al. Engineered E. coli delivers therapeutic genes to the colonic mucosa. Gene Ther.12(13), 1070–1078 (2005).
   PubMed Web of Science ®Google Scholar
• Jain V, Mekalanos JJ. Use of λ phage S and R gene products in an inducible lysis system for Vibrio cholerae- and Salmonella enterica serovar Typhimurium-based DNA vaccine delivery systems. Infect. Immun.68(2), 986–989 (2000).
   PubMed Web of Science ®Google Scholar
• Dietrich G, Hess J, Gentschev I, Knapp B, Kaufmann SH, Goebel W. From evil to good: a cytolysin in vaccine development. Trends Microbiol.9(1), 23–28 (2001).
   PubMed Web of Science ®Google Scholar
• Harris RS, Liddament MT. Retroviral restriction by APOBEC proteins. Nat. Rev. Immunol.4(11), 868–877 (2004).
   PubMed Web of Science ®Google Scholar
• Malim MH. Natural resistance to HIV infection: The Vif–APOBEC interaction. CR Biol.329(11), 871–875 (2006).
   Google Scholar
• Chiu YL, Witkowska HE, Hall SC et al. High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition. Proc. Natl Acad. Sci. USA103(42), 15588–15593 (2006).
   PubMed Web of Science ®Google Scholar
• Salzberg SL, White O, Peterson J, Eisen JA. Microbial genes in the human genome: lateral transfer or gene loss? Science292(5523), 1903–1906 (2001).
   PubMed Web of Science ®Google Scholar
• Stanhope MJ, Lupas A, Italia MJ, Koretke KK, Volker C, Brown JR. Phylogenetic analyses do not support horizontal gene transfers from bacteria to vertebrates. Nature411(6840), 940–944 (2001).
   PubMed Web of Science ®Google Scholar
• Genereux DP, Logsdon JM Jr. Much ado about bacteria-to-vertebrate lateral gene transfer. Trends Genet.19(4), 191–195 (2003).
   PubMed Web of Science ®Google Scholar
• Diaz-Garcia FJ, Herrera-Mendoza AP, Giono-Cerezo S, Guerra-Infante FM. Mycoplasma hominis attaches to and locates intracellularly in human spermatozoa. Hum. Reprod.21(6), 1591–1598 (2006).
   PubMed Web of Science ®Google Scholar
• Fenn K, Blaxter M. Wolbachia genomes: revealing the biology of parasitism and mutualism. Trends Parasitol.22(2), 60–65 (2006).
   Google Scholar
• Chen LM, Briones G, Donis RO, Galan JE. Optimization of the delivery of heterologous proteins by the Salmonella enterica serovar Typhimurium type III secretion system for vaccine development. Infect. Immun.74(10), 5826–5833 (2006).
   PubMed Web of Science ®Google Scholar